The Hidradenitis Suppurativa (HS) Clinical Research Study (30 Weeks)

For condition: Hidradenitis Suppurativa

The Hidradenitis Suppurativa (HS) Clinical Research Study (30 Weeks)

Study Summary

Who Can Participate?
Adults ages 18+ with moderate to severe hidradenitis suppurativa (HS) may be eligible to participate.

Inclusion Criteria

  • Has experienced HS symptoms for at least 6 months
  • Have HS lesions present in least 2 distinct body areas
  • Have HS defined as a total of >5 inflammatory lesions (i.e, number of abscesses plus number of inflammatory nodules)
  • Have either had an inadequate response, intolerance, recurrence, or had a contraindication to oral antibiotics for treatment of HS

Participant Information

  • Participate and receive study treatment at no cost
  • Regular visits with study doctors who specialise in treating HS (12 visits)
  • Will receive either an investigative injection treatment (study drug) or a placebo
  • Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

  • Participants will be asked to visit the study centre about 12 times over a period of about 30 weeks

Note: This study is sponsored by Sanofi-Aventis Canada Inc.

Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial